Abstract: Disclosed are a webpage rendering method and apparatus, a device, and a storage medium, and belong to the field of webpage development technologies. The method includes operating a front-end plugin in a front-end application, the front-end plugin being uncoupled from a server-side plugin, and the server-side plugin being configured to provide a webpage rendering function at a server side; requesting the server-side plugin to render a webpage source code of the webpage through the front-end plugin in response to an open operation for a webpage; and receiving a rendering result of the webpage sent by the server-side plugin through the front-end plugin.

Abstract: The present invention relates to the technical field of new materials, and relates to a thermal conduction enhanced organic composite shape-stabilized phase change material and a preparation method thereof. A thermal conduction enhanced organic composite shape-stabilized phase change material, which is composed of a coordination crosslinked network polymer, an organic solid-liquid phase change material and a thermal conduction enhancer, the mass percent are as follows: coordination crosslinked network polymer 1-50%, organic solid-liquid phase change material 40-98.9%, and thermal conduction enhancer 0.1-10%, the coordination crosslinked network polymer being formed by complexing of polymer compound with metal ions. The invention has simple synthesis process and convenient applications, the material having large enthalpy of phase change, excellent shape stabilizing effect, while the phenomenon of liquid leakage will not occur during operation.

Abstract: A composite material is applicable for photothermal energy conversion and thermal energy storage form-stable phase change. The composite material includes a supporting material and an organic phase-change material. The mass ratio of the supporting material to the organic phase change material is 3:7 to 1:9. The supporting material is lamellar, and the organic phase change material is evenly filled between supporting material layers to form a layered stacked structure. The supporting material is a nanosheet of Ti2C, Ti3C2, Ti3CN, V2C, Nb2C, TiNBC, Nb4C3, TA4C3, (Ti0.5Nb0.5)2C, or (V0.5Cr0.5)3C2. The organic phase-change material is paraffin, fatty acid, fatty acid ester or alcohol compound.

Abstract: The present invention relates to the technical field of new materials, and relates to a thermal conduction enhanced organic composite shape-stabilized phase change material and a preparation method thereof. A thermal conduction enhanced organic composite shape-stabilized phase change material, which is composed of a coordination crosslinked network polymer, an organic solid-liquid phase change material and a thermal conduction enhancer, the mass percent are as follows: coordination crosslinked network polymer 1-50%, organic solid-liquid phase change material 40-98.9%, and thermal conduction enhancer 0.1-10%, the coordination crosslinked network polymer being formed by complexing of polymer compound with metal ions. The invention has simple synthesis process and convenient applications, the material having large enthalpy of phase change, excellent shape stabilizing effect, while the phenomenon of liquid leakage will not occur during operation.

Abstract: A semiconductor package including a plurality of stacked semiconductor die, and methods of forming the semiconductor package, are disclosed. In order to ease wirebonding requirements on the controller die, the controller die may be mounted directly to the substrate in a flip chip arrangement requiring no wire bonds or footprint outside of the controller die. Thereafter, a spacer layer may be affixed to the substrate around the controller die to provide a level surface on which to mount one or more flash memory die. The spacer layer may be provided in a variety of different configurations.

Abstract: A semiconductor package including a plurality of stacked semiconductor die, and methods of forming the semiconductor package, are disclosed. In order to ease wirebonding requirements on the controller die, the controller die may be mounted directly to the substrate in a flip chip arrangement requiring no wire bonds or footprint outside of the controller die. Thereafter, a spacer layer may be affixed to the substrate around the controller die to provide a level surface on which to mount one or more flash memory die. The spacer layer may be provided in a variety of different configurations.

Abstract: A semiconductor device, and a method of its manufacture, are disclosed. The semiconductor device includes a semiconductor die, such as a controller die, mounted on a surface of a substrate. Pillars, for example of solder, may also formed on the substrate, around the semiconductor die. The pillars are formed to a height above the substrate that is greater than the height of the substrate-mounted semiconductor die, including any wire bonds, above the substrate. A second group of one or more semiconductor die, such as flash memory die, may be affixed to the substrate, on top of the solder pillars without contacting the substrate-mounted semiconductor die.

Abstract: A semiconductor wafer, die and semiconductor package formed therefrom are disclosed, where the inactive surface of the wafer has an extrinsic gettering pattern formed from a texturing process. In examples, the texturing process follows a polishing process that removes stress concentration point from the inactive surface of the wafer.

Abstract: Although the fields of therapeutic applications of dendritic cells are now expanding, dendritic cell precursors exist only in a small amount in the peripheral blood and, therefore, it is still difficult to obtain them in a therapeutically useful amount even though they are proliferated in vitro. Therefore, it is a key point in performing a therapy with the use of dendritic cells in practice to elevate dendritic cell precursor level in the peripheral blood of a patient. The present invention provides an agent for elevating dendritic cell precursor level in the blood which comprises an agonist to a receptor expressed in immature dendritic cells or a functional derivative thereof as the active ingredient.

Abstract: Although the fields of therapeutic applications of dendritic cells are now expanding, dendritic cell precursors exist only in a small amount in the peripheral blood and, therefore, it is still difficult to obtain them in a therapeutically useful amount even though they are proliferated in vitro. Therefore, it is a key point in performing a therapy with the use of dendritic cells in practice to elevate dendritic cell precursor level in the peripheral blood of a patient. The present invention provides an agent for elevating dendritic cell precursor level in the blood which comprises an agonist to a receptor expressed in immature dendritic cells or a functional derivative thereof as the active ingredient.

Abstract: Although the fields of therapeutic applications of dendritic cells are now expanding, dendritic cell precursors exist only in a small amount in the peripheral blood and, therefore, it is still difficult to obtain them in a therapeutically useful amount even though they are proliferated in vitro. Therefore, it is a key point in performing a therapy with the use of dendritic cells in practice to elevate dendritic cell precursor level in the peripheral blood of a patient. The present invention provides an agent for elevating dendritic cell precursor level in the blood which comprises an agonist to a receptor expressed in immature dendritic cells or a functional derivative thereof as the active ingredient.